Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 03/31/2021 (updated monthly) $1,449.4 (M)
Net Assets - Class R6 As of 03/31/2021 (updated monthly) $16.5 (M)
P/E Ratio (12-mo Forward)As of 03/31/2021 (updated monthly) 13.39
P/B RatioAs of 03/31/2021 (updated monthly) 5.13

Positions As of 03/31/2021

Portfolio Details

Asset AllocationAs of 03/31/2021

[name] [value]
Equity 97.75%
Cash & Cash Equivalents 2.25%

Geographic BreakdownAs of 03/31/2021

[name] [value]
United States 91.53%
Cash & Cash Equivalents 2.25%
Denmark 1.98%
Canada 1.92%
Switzerland 1.10%
Netherlands 1.08%
United Kingdom 0.14%

sector breakdownAs of 03/31/2021

[name] [value]
Biotechnology 76.87%
Pharmaceuticals 14.81%
Life Sciences Tools & Services 4.00%
Cash & Cash Equivalents 2.25%
Diversified Capital Markets 1.59%
Other Diversified Financial Services 0.35%
Health Care Facilities 0.14%

TOP TEN HOLDINGSAs of 03/31/2021

39.76%
Other
0% 100%
[holdings-table-heading]
GILEAD SCIENCES INC 6.19%
AMGEN INC 5.47%
REGENERON PHARMACEUTICALS INC 4.52%
VERTEX PHARMACEUTICALS INC 4.15%
ILLUMINA INC 4.00%
HORIZON PHARMA PLC 3.47%
BIOGEN INC 3.28%
IOVANCE BIOTHERAPEUTICS INC 3.05%
NOVAVAX INC 3.02%
PTC THERAPEUTICS INC 2.61%